ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News: The human trial of COVID-19 vaccine named ChAdOx1 nCoV-19 vaccine developed by the University of Oxford and backed by AstraZeneca Plc has shown a positive result.
Facts:
- How was the vaccine produced? The vaccine was made from a genetically engineered virus(adenovirus) that causes the common cold in chimpanzees.
- However, the virus was heavily modified so that it cannot cause infections in people and look a bit like the coronavirus that produces spike protein that the virus uses to enter and infect human cells.
- What was the response? The first phase of clinical trials did not prompt any serious side effects and produced antibodies and T-cells that can fight coronavirus.
Additional Facts:
- Antibodies: It is a protective protein produced by the immune system in order to attack antigens.Antigen is a toxin or other foreign substance which induces an immune response in the body.
- T-cells: It is a type of white blood cell that helps coordinate the immune system and are able to spot which of the body’s cells have been infected and destroy them.
